Stocks
Novo Nordisk (NVO) ROE US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | 5 years average | |||
| ROE, % | ? | 67.5% | 66.5% | 78.5% | 70.4% | 52.8% | 60.1% | ||
| Changes by years, y/y, % | -337pp | -1pp | +12pp | -8pp | -18pp | 67% | |||
Novo Nordisk. ROE, %
Novo Nordisk. ROE, changes, pp
Novo Nordisk (NVO) ROE US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| ROE, % | ? | 66.1% | 61.1% | 52.8% | 60.1% | 52.6% | 60.1% | |
| Changes by years, y/y, % | -490pp | -18pp | -18pp | -15pp | -13pp | |||
| Changes by quarters, q/q, % | -9pp | -5pp | -8pp | +7pp | -7pp | |||
